Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06557317 · ClinicalTrials.gov registry record · NA

In-Person Lifestyle Program for Black Adolescent Girls at Risk for Type 2 Diabetes

A NA study of Diabetes Mellitus, Type 2 and Overweight, sponsored by Cornell University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06557317 is a NA study of Diabetes Mellitus, Type 2 and Overweight that is actively recruiting participants, run by Cornell University. The registered enrollment target is 60 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06557317, a NA study of Diabetes Mellitus, Type 2 and Overweight, is actively recruiting participants, sponsored by Cornell University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to look at changes in diabetes-related risk factors in Black adolescent girls who are at risk for type 2 diabetes and their primary female caregiver after both participating in a 12-week in-person lifestyle program.

Interventions

  • BEHAVIORAL Black Girls for Wellness In-Person

Study Locations (1)

New York

  • Brownsville Neighborhood Health Action Center - Brooklyn

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-08
Est. Completion 2024-12-31
Phase NA

Sponsor

Cornell University

66 total trials

What the Registry Record Tells You About NCT06557317

The ClinicalTrials.gov registry entry for NCT06557317 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The listed sponsor is Cornell University, which has 66 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which Black Girls for Wellness In-Person is the first listed.

NCT06557317 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06557317 about?

NCT06557317 is a clinical study titled "In-Person Lifestyle Program for Black Adolescent Girls at Risk for Type 2 Diabetes". The aim of this study is to look at changes in diabetes-related risk factors in Black adolescent girls who are at risk for type 2 diabetes and their primary female caregiver after both participating in a 12-week in-person lifestyle program.

What is the current status of trial NCT06557317?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-08. Estimated completion is 2024-12-31.

What conditions does trial NCT06557317 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Overweight, Pediatric Obesity, Childhood Obesity, Metabolic Disease.

What interventions are being tested in trial NCT06557317?

The interventions under investigation include: Black Girls for Wellness In-Person (BEHAVIORAL).

Who is sponsoring clinical trial NCT06557317?

This trial is sponsored by Cornell University, which has 66 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06557317 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus, Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.